Skip to main content
. 2024 May 10;16(10):1351. doi: 10.3390/polym16101351

Table 2.

Evaluation of antimicrobial activity of chitosan-based formulations against various microorganisms, with special observations and supporting references.

S. No. Type of Formulation Size of NP/Fibres Microbes Special Comments References
1. Bletilla striata (BSP) film 0.097 ± 0.004 to 0.136 ± 0.003 mm thickness Escherichia coli
staphylococcus aureus and Pseudomonas
aeruginosa
In this study, the author reported that the prepared BSP/CS films may be used to create biomaterials for new wound dressings. [81]
2. Eucalyptus-oil-loaded chitosan nanofibres 48.26 nm Staphylococcus aureus The developed nano-chitosan/Eucalyptus oil/cellulose acetate nanofibre has excellent antimicrobial properties and shows promise as a wound healing dressing. [82]
3. CSNPs 141.20 nm S. aureus and P. aeruginosa The dose-dependent antibacterial activity was observed. [83]
4. Lecithin-coated CSNPs 235 ± 20 nm S. aureus A 2-fold decrease in the survival rate of S. aureus was observed. [84]
5. CS-AgNPs 10–30 nm Methicillin-resistant streptococcus aureus (MRSA) MRSA was not detected in all treated groups. [85]
6. CSNPs 408.30 ± 53.17 nm S. aureus More than 90% inhibition rate was observed in CSNP-treated groups. [86]
7. AgNPs - S. aureus, P. aeruginosa, and E. coli The prepared sponges loaded with AgNPs show excellent antibacterial activity against S. aureus, P. aeruginosa, and E. coli. [87]
8. CS-AgNPs 10–50 nm MRSA and P. aeruginosa The CS-AgNPs show good antibacterial activity against MRSA and P. aeruginosa. [88]
9. CS-AgNPs 22.80 nm E. coli The CS film loaded with CS-AgNPs showed higher inhibition against E. coli compared to CS-AgNP solution. [89]
10. CS fibres - Escherichia coli, Staphylococcus aureus, and Candida albicans The prepared fibres showed excellent antibacterial activity. [90]
11. CS nanofibres 140–170 E. coli and S. aureus The CS nanofibres loaded with cinnamon extract enhance the antibacterial activity. [91]
12. CSNPs 208.40 ± 15.70 nm E. coli and S. aureus The CSNPs show dose-dependent antibacterial activity and have greater effect against S. aureus than E. coli. [92]
13. CSNPs 51.67 ± 12.55 nm S. aureus, P. aeruginosa, E. coli, B. subtilis, and C. albicans The CSNP loaded with SSD show greater effect against gram +ve bacteria than gram −ve bacteria. [93]
14. AgNPs 5–10 nm Staphylococcus aureus and Pseudomonas aeruginosa The 3D scaffold loaded with AgNPs showed excellent antibacterial activity. [94]

E. coliEscherichia coli; S. aureusStaphylococcus aureus; C. albicansCandida albicans; SSD—silver sulfadiazine; CS—chitosan; AgNPs—silver nanoparticles; MRSA—Methicillin-resistant Staphylococcus aureus.